Outcomes in patients with hyperglycemia affected by covid-19: Can we do more on glycemic control?
C Sardu, Nunzia D’Onofrio, et al. Balestrieri ML
Abstract
Short summary: In this observational cohort of hospitalised COVID-19 patients in Italy, patients who had hyperglycaemia, with or without diabetes, were at higher risk for severe COVID disease than normoglycaemic patients. Insulin infusion was effective for achieving glycaemic targets and reducing mortality in patients with COVID-19.
Topics & Concepts
GlycemicMedicineCoronavirus disease 2019 (COVID-19)Diabetes mellitusObservational study2019-20 coronavirus outbreakInternal medicineInsulinCohortSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseCohort studyIntensive care medicineEndocrinologyVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research